Jump to content

Talk:RET proto-oncogene

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

Formerly MEN2a/2b

[edit]

MEN2a and 2b are the CURRENT names, MEN 3 is outdated following the discovery that MEN2B was caused by a mutation to the same gene (met->thr mutation on RET). I've changed the article accordingly. —Preceding unsigned comment added by ChillyMD (talkcontribs) 13:53, 23 January 2009 (UTC)[reply]

As a drug target

[edit]

Cabozantinib Improves Outcomes Over Erlotinib in Advanced NSCLC says cabozantinib is also an inhibitor of RET and ROS1. May explain good results in NSCLC. - Rod57 (talk) 11:59, 3 December 2016 (UTC)[reply]